Access Quebec (INESSS)
The Council for Continuing Pharmaceutical Education (CCPE) course Pharmaceutical Market Access in Canada provides a comprehensive overview of the market access environment in Canada. It’s recommended, but not a pre-requisite, that you complete that course first to obtain the basic understanding of the dynamics in market access.
This course, Understanding Market Access Submissions: Public Payer Series for Quebec (INESSS), focusses on understanding the roles and responsibilities of the key players in market access in Quebec, the main components of a formulary submission and pertinent insights as to why Quebec is asking for certain information.
Completion of this course should help industry professionals better prepare more robust formulary submissions to meet Quebec’s reimbursement objectives. This course will be invaluable to other team members within the pharmaceutical company (e.g. sales, marketing, medical, regulatory departments) as they all directly or indirectly influence, and/or are impacted by the formulary submission strategy and dossier. Other team members, outside the formal market access department, will also better understand what is similar or different in the value proposition that will resonate for payers vs prescribers.
After completing the course, students will be able to:
- Describe the submission process for listing on the Quebec drug formulary
- Discuss where to find the latest submission processes
54 multiple choice questions.
- Suggested Hours of Study 9
- Quizzes 0
- Suggested Hours of Study 7 hrs
- Course Completion 3 months
- Course Format Paper
- RxTx No
- Language English
- Pages 72 pages
- C.E. Credits What is this? 1
- Orientation Package
- # of Questions 54
- Time Limit 65 min
- Passing Grade 60%
- Price $1000.00
- Corporate Member $500.00
- Corporate Non-Member $2,500.00
SECTION 1: INTRODUCTION
SECTION 2: OVERVIEW OF THE CANADIAN MARKET ACCESS LANDSCAPE
MODULE 1: Key Stakeholders in Market Access
SECTION 2 (contd.): OVERVIEW OF THE CANADIAN MARKET ACCESS LANDSCAPE
Module 2: Overview of the Drug Reimbursement Review Process in Canada
SECTION 3: PUBLIC PAYER SUBMISSIONS FOR BRAND DRUG PRODUCTS
MODULE 1: Submissions
SECTION 3 (contd.): PUBLIC PAYER SUBMISSIONS FOR BRAND DRUG PRODUCTS
MODULE 2: Provincial Submission Process